NEW YORK, September 30, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Investors' Reports announced new research reports highlighting MAKO Surgical Corp. (NASDAQ:MAKO), Intuitive Surgical, Inc. (NASDAQ:ISRG), Medtronic, Inc. (NYSE:MDT), Zimmer Holdings, Inc. (NYSE:ZMH), and Varian Medical Systems, Inc. (NYSE:VAR). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
MAKO Surgical Corp. Research Report
On September 25, 2013, MAKO Surgical Corp. ( MAKO ) announced that it has entered into a definitive agreement with Stryker Corporation (Stryker). Under the agreement, Stryker will acquire all of the outstanding shares of MAKO for $30.00 per share in cash, for an aggregate purchase price of approximately $1.7 billion. Maurice R. Ferré, M.D., President and CEO of MAKO, stated, "The combination of Stryker's established industry leadership with MAKO's innovative products and people contains the power to positively transform orthopedics." Ferré continued, "It is with this in mind that MAKO's board of directors unanimously voted to recommend that MAKO's shareholders vote in favor of it." MAKO further reported that the transaction is subject to customary closing conditions, including MAKO stockholders approval. The Full Research Report on MAKO Surgical Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.InvestorsReports.com/report/2013-09-25/MAKO]
Intuitive Surgical, Inc. Research Report
On September 25, 2013, Intuitive Surgical, Inc. (Intuitive Surgical) announced that it will host its Q3 2013 conference call on Thursday, October 17, 2013, at 4:30 p.m. ET. Intuitive Surgical reported that the call will be webcast by Thomson Reuters, and is accessible through the Company's website. The Company noted that the call will also be distributed to both institutional and individual investors over Thomson Reuters Investor Distribution Network. The Full Research Report on Intuitive Surgical, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.InvestorsReports.com/report/2013-09-25/ISRG]
Medtronic, Inc. Research Report
On September 23, 2013, Medtronic, Inc. (Medtronic) announced positive clinical trial results showing nearly 50% reduced risk of atrial fibrillation for heart failure patients treated with Medtronic AdaptivCRT. The Company reported that the AdaptivCRT technology is a feature on certain cardiac resynchronization therapy-defibrillators (CRT-Ds) that continually adjusts therapy to a patient's natural heart rhythms and minimizes the amount of unnecessary right ventricular (RV) pacing. David Steinhaus, M.D., Vice President and General Manager, Heart Failure, and Medical Director for the Cardiac Rhythm Disease Managements business at Medtronic, commented, "The AdaptivCRT technology is a novel approach to CRT-D that continually and automatically adjusts the therapy to the heart rhythm for each individual patient." Steinhaus added, "The results of the Adaptive CRT trial will be significant as the 'baby boomer' population ages and becomes more vulnerable to heart failure and associated conditions such as atrial fibrillation." The Full Research Report on Medtronic, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.InvestorsReports.com/report/2013-09-25/MDT]
Zimmer Holdings, Inc. Research Report
On September 9, 2013, Zimmer Holdings, Inc. (Zimmer) announced that its Board of Directors has authorized the payment of a $0.20 cash dividend per share to stockholders for Q3 2013. Zimmer reported that the cash dividend will be paid on or about October 25, 2013, to stockholders of record at the close of business on September 27, 2013. The Full Research Report on Zimmer Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.InvestorsReports.com/report/2013-09-25/ZMH]
Varian Medical Systems, Inc. Research Report
On September 19, 2013, Varian Medical Systems, Inc. (Varian) announced the first two planned system installations of EdgeTM Radiosurgery Suite, a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. Chris Toth, Vice President of Marketing for Varian's Oncology Systems business, said, "We are pleased to announce the first two installations will be at the Champalimaud Foundation in Lisbon, Portugal and Henry Ford Health System in Detroit, Michigan." Toth continued, "Champalimaud Foundation represents our first installation in Europe and Henry Ford Health System our first in North America. The institutions represent and embody clinical excellence and we are thrilled that we get to launch this exciting new platform into clinical use with them." The Full Research Report on Varian Medical Systems, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.InvestorsReports.com/report/2013-09-25/VAR]
This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investors' Reports